|
Lozano-Gil JM, Rodriguez-Ruiz L, Palacios M, Peral J, Navarro S, Fuster JL, Belendez C, Jerez A, Murillo-Sanjuan L, Diaz-de-Heredia C, Lopez-de-Hontanar G, Zubicaray J, Sevilla J, Ferrer-Marin F, Sepulcre MP, Cayuela ML, Garcia-Moreno D, Martinez-Lopez A, Tyrkalska SD, Mulero V. TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome. EMBO Mol Med. 2026 Jan 9. doi: 10.1038/s44321-025-00368-3. Online ahead of print. PubMed PMID: 41514124.
AÑO: 2026; IF: 8.3
|
41514124
|
Rodriguez-Ruiz L, Lozano-Gil JM, Ocana-Esparza M, Conesa-Hernandez AM, Perez-Oliva AB, Fuster JL, Jerez A, Murillo-Sanjuan L, Diaz-de-Heredia C, Lopez-de-Hontanar G, Sevilla J, Garcia-Moreno D, Cayuela ML, Martinez-Lopez A, Tyrkalska SD, Mulero V. Spironolactone inhibits the NLRP1 inflammasome and alleviates defective erythropoiesis in Diamond-Blackfan anemia. Hemasphere. 2025 Apr 17;9(4):e70131. doi: 10.1002/hem3.70131. eCollection 2025 Apr. No abstract available. PubMed PMID: 40248129; PubMed Central PMCID: PMC12005213.
AÑO: 2025; IF: 14.6
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. PubMed PMID: 37368200.
AÑO: 2024; IF: 2.5
|
|
Hidalgo-Gomez G, Minguela A, Tazon-Vega B, Ribera J, Galian JA, Martinez-Banaclocha H, Garcia-Garay M, Velasco P, Fuster-Soler JL, Armengol G, Ortega M. Clonal heterogeneity and genomic evolution in intrachromosomal amplification of chromosome 21: A case report. Br J Haematol. 2024 Jun;204(6):2512-2515. doi: 10.1111/bjh.19485. Epub 2024 Apr 26. No abstract available. PubMed PMID: 38665061.
AÑO: 2024; IF: 3.8
|
|
Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Gonzaalez Martinez B, Fuentes C, Molinos A, Guerra-Garcia P, Palomo P, Verdu J, Adan Pedroso RM, Vagace JM, Lopez-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta A, Lendinez F, Rives S, Pascual A, Rodriguez A, Perez-Hurtado JM, Fernandez JM, Perez-Martinez A, Gonzalez-Vicent M, Diaz de Heredia C, Fuster JL. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet). Front Pediatr. 2023 Mar 20;11:1140637. doi: 10.3389/fped.2023.1140637. eCollection 2023. PubMed PMID: 37020654; PubMed Central PMCID: PMC10067875.
AÑO: 2023; IF: 2.1
|